(Q44557222)

4 December 2017

title

Apolipoprotein B/AI ratio is independently associated with non-alcoholic fatty liver disease in nondiabetic subjects (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

4 December 2017

main subject

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

Young Gil Choe

1

1 reference

4 December 2017

Wook Jin

2

1 reference

4 December 2017

Yong Kyun Cho

3

1 reference

4 December 2017

Won Gil Chung

4

1 reference

4 December 2017

Hong Joo Kim

5

1 reference

4 December 2017

Woo Kyu Jeon

6

1 reference

4 December 2017

Byung Ik Kim

7

1 reference

4 December 2017

publication date

1 April 2013

1 reference

Journal of Gastroenterology and Hepatology

4 December 2017

published in

1 reference

4 December 2017

volume

28

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

678-683

1 reference

Nonalcoholic fatty liver disease

4 December 2017

cites work

1 reference

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

Fatty liver incidence and predictive variables

21 January 2018

1 reference

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

21 January 2018

1 reference

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans.

21 January 2018

1 reference

Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy

21 January 2018

1 reference

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

21 January 2018

1 reference

Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease.

21 January 2018

1 reference

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

21 January 2018

1 reference

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study

21 January 2018

1 reference

Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM).

21 January 2018

1 reference

Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study.

21 January 2018

1 reference

Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies

21 January 2018

1 reference

Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome.

21 January 2018

1 reference

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

21 January 2018

1 reference

The utility of radiological imaging in nonalcoholic fatty liver disease.

21 January 2018

1 reference

Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse.

21 January 2018

1 reference

Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy

21 January 2018

1 reference

The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects

21 January 2018

1 reference

Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects

21 January 2018

1 reference

Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis

21 January 2018

1 reference

Adiponectin and Metabolic Syndrome

21 January 2018

1 reference

Apolipoprotein synthesis in nonalcoholic steatohepatitis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.12077

1 reference

4 December 2017

1 reference